oxybutynin has been researched along with Cystitis, Interstitial in 7 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Cystitis, Interstitial: A condition with recurring discomfort or pain in the URINARY BLADDER and the surrounding pelvic region without an identifiable disease. Severity of pain in interstitial cystitis varies greatly and often is accompanied by increased urination frequency and urgency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravesical instillation of TRG-100 was found to be safe and efficient in reducing pain and irritative bladder symptoms in our study population." | 5.91 | Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St ( Ala-Adin, N; Chertin, B; Dothan, D; Gordon, A; Hatumi, S; Kafka, I; Malchi, N; Moldwin, R; Nassar, T; Perez, D; Raisin, G; Shenfeld, O; Touitou, D, 2023) |
| "Interstitial cystitis is a condition with a poorly understood etiology and, consequently, various treatment options have been described in the literature, with a less than optimal outcome." | 2.73 | A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis. ( Jawade, KK; Taneja, R, 2007) |
| "Intravesical instillation of TRG-100 was found to be safe and efficient in reducing pain and irritative bladder symptoms in our study population." | 1.91 | Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St ( Ala-Adin, N; Chertin, B; Dothan, D; Gordon, A; Hatumi, S; Kafka, I; Malchi, N; Moldwin, R; Nassar, T; Perez, D; Raisin, G; Shenfeld, O; Touitou, D, 2023) |
| "Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic debilitating condition of unknown etiology." | 1.72 | Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study. ( Chertin, B; Dothan, D; Gordon, A; Malchi, N; Raisin, G; Touitou, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dothan, D | 2 |
| Raisin, G | 2 |
| Malchi, N | 2 |
| Gordon, A | 2 |
| Touitou, D | 2 |
| Chertin, B | 2 |
| Perez, D | 1 |
| Ala-Adin, N | 1 |
| Kafka, I | 1 |
| Shenfeld, O | 1 |
| Hatumi, S | 1 |
| Moldwin, R | 1 |
| Nassar, T | 1 |
| Matsuoka, PK | 1 |
| Haddad, JM | 1 |
| Pacetta, AM | 1 |
| Baracat, EC | 1 |
| Osman, NI | 1 |
| Chapple, CR | 1 |
| Taneja, R | 1 |
| Jawade, KK | 1 |
| Barbalias, GA | 1 |
| Liatsikos, EN | 1 |
| Athanasopoulos, A | 1 |
| Nikiforidis, G | 1 |
| Cannon, TW | 1 |
| Chancellor, MB | 1 |
2 reviews available for oxybutynin and Cystitis, Interstitial
| Article | Year |
|---|---|
Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anesthetics, Local; BCG Vaccine; Cystitis, Int | 2012 |
Pharmacotherapy of the overactive bladder and advances in drug delivery.
Topics: Administration, Intravesical; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Botulinum Toxi | 2002 |
2 trials available for oxybutynin and Cystitis, Interstitial
| Article | Year |
|---|---|
A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis.
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Anticoagu | 2007 |
Interstitial cystitis: bladder training with intravesical oxybutynin.
Topics: Administration, Intravesical; Adult; Aged; Cystitis, Interstitial; Female; Humans; Mandelic Acids; M | 2000 |
3 other studies available for oxybutynin and Cystitis, Interstitial
| Article | Year |
|---|---|
Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study.
Topics: Administration, Intravesical; Animals; Cystitis, Interstitial; Delayed-Action Preparations; Lidocain | 2022 |
Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral St
Topics: Administration, Intravesical; Cystitis, Interstitial; Delayed-Action Preparations; Humans; Lidocaine | 2023 |
Lower urinary tract symptoms revisited.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Benzhydryl Compounds; Cresols; Cystitis, Inter | 2012 |